Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosisKazumichi Abe, Hiromasa Ohira, Masahito Kuroda et al.|PLoS ONE|2020Cited by 45
Efficacy of alogliptin in preventing non-alcoholic fatty liver disease progression in patients with type 2 diabetesTsuyoshi Mashitani, Hitoshi Yoshiji, Ryuichi Noguchi et al.|Biomedical Reports|2016Cited by 43